Skip to main content

Advertisement

SpringerLink
Log in

Reverse ELISA for the detection of anti West Nile virus IgG antibodies in humans

  • Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

We have developed a specific reverse ELISA to investigate the potential of the domain III of the West Nile virus envelope protein to detect virus-specific antibodies. For this purpose, the domain III antigen was expressed in Escherichia coli, refolded and directly labelled with peroxidase. By mixing serum samples with the enzyme-labelled antigen, immune complexes will form that are simultaneously recognized by rheumatoid factor coated microtiter plates. Specific antibodies to the domain III were found in 160 out of 206 sera of patients with neutralising antibodies to West Nile virus (77.6% sensitivity). The antigen differentiated reliably between sera of West Nile virus- and dengue virus-infected patients. In combination with indirect immunofluorescence, to exclude four false-positive samples, the specificity was 100% (280 samples). Assuming a prevalence rate of anti-West-Nile virus antibodies of 5%, the positive and negative predictive values were 93.3% and 98.8% respectively. These results indicate that the reverse ELISA using a specific portion of the envelope antigen of West Nile virus is especially suitable for studies on the prevalence of West Nile infections in affected countries.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. CDC (1999) Outbreak of West Nile-like viral encephalitis-New York 1999. MMWR Morb Mortal Wkly Report 48

  2. Johnson AJ, Noga AJ, Kosoy O, Lanciotti RS, Johnson AA, Biggerstaff BJ (2005) Duplex microsphere-based immunoassay for detection of anti-West Nile virus and anti-St. Louis encephalitis virus immunoglobulin m antibodies. Clin Diagn Lab Immunol 12(5):566–574

    Article  PubMed  CAS  Google Scholar 

  3. Tardei G, Ruta S, Chitu V, Rossi C, Tsai TF, Cernescu C (2000) Evaluation of immunoglobulin M (IgM) and IgG enzyme immunoassays in serologic diagnosis of West Nile Virus infection J Clin Microbiol 38(6):2232–2239

    PubMed  CAS  Google Scholar 

  4. Roehrig JT (2003) Antigenic structure of flavivirus proteins. Adv Virus Res 59:141–175

    PubMed  CAS  Google Scholar 

  5. Wong SJ, Demarest VL, Boyle RH, Wang T, Ledizet M, Kar K, Kramer LD, Fikrig E, Koski RA (2004) Detection of human anti-flavivirus antibodies with a West Nile virus recombinant antigen microsphere immunoassay. J Clin Microbiol 42(1):65–72

    Article  PubMed  CAS  Google Scholar 

  6. Niedrig M, Vaisviliene D, Teichmann A, Klockmann U, Biel SS (2001) Comparison of six different commercial IgG-ELISA kits for the detection of TBEV-antibodies. J Clin Virol 20(3):179–182

    Article  PubMed  CAS  Google Scholar 

  7. Hayes EB, Gubler DJ (2006) West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States. Annu Rev Med 57:181–194

    Article  PubMed  CAS  Google Scholar 

  8. Heinz FX, Berger R, Tuma W, Kunz C (1983) A topological and functional model of epitopes on the structural glycoprotein of tick-borne encephalitis virus defined by monoclonal antibodies. Virology 126(2):525–537

    Article  PubMed  CAS  Google Scholar 

  9. Guirakhoo F, Heinz FX, Kunz C (1989) Epitope model of tick-borne encephalitis virus envelope glycoprotein E: analysis of structural properties, role of carbohydrate side chain, and conformational changes occurring at acidic pH. Virology 169(1):90–99

    Article  PubMed  CAS  Google Scholar 

  10. Mandl CW, Guirakhoo F, Holzmann F, Heinz FX, Kunz C (1989) Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model. J Virol 63(2):564–571

    PubMed  CAS  Google Scholar 

  11. Rey FA, Heinz FX, Mandl C, Kunz C, Harrison SC (1995) The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 375(6529):291–298

    Article  PubMed  CAS  Google Scholar 

  12. Kuhn RJ, Zhang W, Rossmann MG, Pletnev SV, Corver J, Lenches E, Jones CT, Mukopadhyay S, Chipman PR, Strauss EG, Bakers TS, Strauss JH (2002) Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108(5):717–725

    Article  PubMed  CAS  Google Scholar 

  13. Fonseca BA, Khoshnood K, Shope RE, Mason PW (1991) Flavivirus type-specific antigens produced from fusions of a portion of the E protein gene with the Escherichia coli trpE gene. Am J Trop Med Hyg 44(5):500–508

    PubMed  CAS  Google Scholar 

  14. Simmons M, Porter KR, Escamilla J, Graham R, Watts DM, Eckels KH, Hayes CG (1998) Evaluation of recombinant dengue viral envelope B domain protein antigens for the detection of dengue complex-specific antibodies. Am J Trop Med Hyg 58(2):144–151

    PubMed  CAS  Google Scholar 

  15. Oliphant T, Engle M, Nybakken GE, Doane C, Johnson S, Huang L, Gorlatov S, Mehlhop E, Marri A, Chung KM, Ebel GD, Kramer LD, Fremeont DH, Diamond MS (2005) Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat Med 11(5):522–530

    Article  PubMed  CAS  Google Scholar 

  16. Ludolfs D, Schilling S, Altenschmidt J, Schmitz H (2002) Serological differentiation of infections with dengue virus serotypes 1 to 4 by using recombinant antigens. J Clin Microbiol 40(11):4317–4320

    Article  PubMed  CAS  Google Scholar 

  17. Beasley DW, Holbrook MR, Travassos da Rosa AP, Coffey L, Carrara AS, Phillippi-Falkenstein K, Bohm RP Jr, Ratterree MS, Lillibridge KM, Ludwig GV, Estrada-Franco J, Weaver SC, Tesh RB, Shope RE, Barrett AD (2004) Use of a recombinant envelope protein subunit antigen for specific serological diagnosis of West Nile virus infection. J Clin Microbiol 42(6):2759–2765

    Article  PubMed  CAS  Google Scholar 

  18. Johnson AJ, Martin DA, Karabatsos N, Roehrig JT (2000) Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay. J Clin Microbiol 38(5):1827–1831

    PubMed  CAS  Google Scholar 

  19. Miyazawa H, Bannai H, Yanase T, Morita C, Satoh S, Sugiyama J, Tanaguchi S, Inouye S (1999) A reverse-sandwich enzyme-linked immunosorbent assay for verocytotoxin 1 and 2 antibodies in human and bovine sera. Clin Diagn Lab Immunol 6(5):701–704

    PubMed  CAS  Google Scholar 

  20. Sachers M, Emmerich P, Mohr H, Schmitz H (1985) Simple detection of antibodies to different viruses using rheumatoid factor and enzyme-labelled antigen (ELA). J Virol Methods 10(2):99–110

    Article  PubMed  CAS  Google Scholar 

  21. Emmerich P, Thome-Bolduan C, Drosten C, Gunther S, Ban E, Sawinsky I, Schmitz H (2006) Reverse ELISA for IgG and IgM antibodies to detect Lassa virus infections in Africa. J Clin Virol 37(4):277–281

    Article  PubMed  CAS  Google Scholar 

  22. Schmitz H, von Deimling U, Flehmig B (1980) Detection of IgM antibodies to cytomegalovirus (CMV) using an enzyme-labelled antigen (ELA). J Gen Virol 50(1):59–68

    Article  PubMed  CAS  Google Scholar 

  23. McIntosh BM, Jupp PG, Dos Santos IS, Meenehan GM (1976) Culex (Eumelanomyia) rubinotus Theobald as vector of Banzi, Germiston and Witwatersand viruses. I. Isolation of virus from wild populations of C. rubinotus. J Med Entomol 12(6):637–640

    PubMed  CAS  Google Scholar 

  24. Jupp PG, Blackburn NK, Thompson DL, Meenehan, GM (1986) Sindbis and West Nile virus infections in the Witwatersrand-Pretoria region. S Afr Med J 70(4):218–220

    PubMed  CAS  Google Scholar 

  25. Schilling S, Ludolfs D, Van An L, Schmitz H (2004) Laboratory diagnosis of primary and secondary dengue infection. J Clin Virol 31(3):179–184

    Article  PubMed  CAS  Google Scholar 

  26. Stich A, Gunther S, Drosten C, Emmerich P, Dwyer DE, Hueston L, Hetzel W, Kirschner A, Fleischer K (2003) Clinical and laboratory findings on the first imported case of Murray Valley encephalitis in Europe. Clin Infect Dis 37(2):e19–21

    Article  PubMed  Google Scholar 

  27. Laue T, Emmerich P, Schmitz H (1999) Detection of dengue virus RNA in patients after primary or secondary dengue infection by using the TaqMan automated amplification system. J Clin Microbiol 37(8):2543–2547

    PubMed  CAS  Google Scholar 

  28. Swanepoel R , Struthers JK, Erasmus MJ, Shepherd SP, McGillivray GM, Erasmus BJ, Barnard BJ (1986) Comparison of techniques for demonstrating antibodies to Rift Valley fever virus. J Hyg (Lond) 97(2):317–329

    CAS  Google Scholar 

  29. Avrameas S (1975) Studies on antibody formation with enzyme markers. Ann N Y Acad Sci 254:175–189

    Article  PubMed  CAS  Google Scholar 

  30. Wengler G, Wengler G (1989) An analysis of the antibody response against West Nile virus E protein purified by SDS-PAGE indicates that this protein does not contain sequential epitopes for efficient induction of neutralising antibodies. J Gen Virol 70(Pt 4):987–992

    PubMed  CAS  Google Scholar 

  31. Kuno G, Gubler DJ, Oliver A (1993) Use of ’original antigenic sin’ theory to determine the serotypes of previous dengue infections. Trans R Soc Trop Med Hyg 87(1):103–105

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Jan ter Meulen, Crucell, Leiden, The Netherlands and Christa Pfleiderer, Paul Ehrlich Institute, Langen, Germany for providing serum samples for the validation. We also thank Inga Nehlmeier from the Robert Koch Institute, Berlin, Germany and Stefan Linckh, Bernhard Nocht Institute Hamburg for technical assistance.

This study was supported by the Bundesministerium für Gesundheit, grant no. 1368–544, “Prävalenz und Inzidenz von West-Nil-Virus in Deutschland”. We declare that the experiments comply with the currents laws of the country in which they were performed.

Author information

Authors and Affiliations

  1. Department of Virology, Bernhard Nocht Institute for Tropical Medicine, Bernhard Nocht Str. 74, 20356, Hamburg, Germany

    D. Ludolfs & H. Schmitz

  2. ZBS1, Robert Koch Institute, Nordufer 20, 13353, Berlin, Germany

    M. Niedrig

  3. Special Pathogens Unit, National Institute for Communicable Diseases, 1 Modderfontein Road, Sandringham, 2131, South Africa

    J. T. Paweska

Authors
  1. D. Ludolfs
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Niedrig
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. T. Paweska
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Schmitz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. Schmitz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ludolfs, D., Niedrig, M., Paweska, J.T. et al. Reverse ELISA for the detection of anti West Nile virus IgG antibodies in humans. Eur J Clin Microbiol Infect Dis 26, 467–473 (2007). https://doi.org/10.1007/s10096-007-0309-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-007-0309-1

Keywords

Search

Navigation